Clinical Trial

Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the trial is to explore the effect of exogenous postbiotics supply on the quality of life and nutritional status of elderly hemodialysis patients. Participants will be devided into intervention group and placebo group in an 1:1 ratio.They will: 1. In the treatment period for 12 weeks, intervention group receives postbiotics product while the other group receives placebo. 2. In the subsequent 12 weeks, intervention group ends the trial and placebo group enters into remedial treatment period. Placebo group will receive postbiotics product for 12 weeks. Researchers will analyze the change of indicators such as quality of life and nutrition state of participants from the baseline to end of treatment, and compare the difference between the two group.
Trial Details
NCT Number NCT06975995
Lead Sponsor Peking University First Hospital
Conditions Hemodialysis Complication
Enrollment 60 participants
Start Date 2024-08-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-16